Investigating the feasibility of recruitment to an observational, quality-of-life study of patients diagnosed with atrial fibrillation (AF) who have experienced a bleed while anticoagulated: EQUAL-AF feasibility study protocol

• Published in: Pilot and feasibility studies Vol. 8; no. 1; pp. 1 - 180
• Main Authors: Hutchings, Hayley A, Lanyon, Kirsty, Lister, Steven, Alikhan, Raza, Halcox, Julian, Holland, Gail, Hughes, Arfon, Jenkins, Rhys, Laing, Hamish, Lobban, Trudie, Owen, Diane, Pollock, Kevin G, Todd, Ceri, Wareham, Kathie
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 12.08.2022; BioMed Central; BMC
• Subjects: Analysis; Anticoagulants; Atrial fibrillation; Bleeding; Cardiac arrhythmia; Consent; Coronaviruses; COVID-19; Disease; Feasibility; Feasibility studies; Health aspects; Heart; Heart beat; Heart rate; Hospitals; Measuring instruments; Medical research; Medicine, Experimental; Mortality; Patient-reported outcome measures; Patients; Primary care; Protocol; Public health; QoL; Quality of life; Stroke; Study Protocol; Thromboembolism; Virtual communities; United Kingdom > UK

Background Oral anticoagulation therapies (OATs) are often prescribed in conjunction with medications to restore normal heart rate rhythm which can limit the risk of an atrial fibrillation (AF) related stroke and systemic thromboembolism. However, they are associated with the serious side effect of...